PGNY vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

PGNY

59.5
AI Score
VS
PGNY Wins

CLOV

52.4
AI Score

Investment Advisor Scores

PGNY

60score
Recommendation
BUY

CLOV

52score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PGNY CLOV Winner
Forward P/E 11.8906 81.9672 PGNY
PEG Ratio 0 0 Tie
Revenue Growth 5.3% 55.6% CLOV
Earnings Growth 78.9% 0.0% PGNY
Tradestie Score 59.5/100 52.4/100 PGNY
Profit Margin 6.0% -0.7% PGNY
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

PGNY 1M: +7.6% · 3M: +6.6% CLOV 1M: +6.2% · 3M: -1.6%

Current Technical Phase

PGNY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.8 · Price: $27.35

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.4 · Price: $4.82

Fundamentals Snapshot

Metric PGNY CLOV
Market Cap
Forward P/E 11.8 32.1
Trailing P/E 29.4
Revenue (TTM)
Revenue Growth 0.1% 0.6%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.0%
EPS 0.92 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PGNY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.